Deutsche Bank’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-16,816
| Closed | -$504K | – | 4208 |
|
|
2021
Q3 | $504K | Sell |
16,816
-8,981
| -35% | -$269K | ﹤0.01% | 3011 |
|
|
2021
Q2 | $1.2M | Buy |
25,797
+23,103
| +858% | +$1.07M | ﹤0.01% | 2652 |
|
|
2021
Q1 | $162K | Buy |
2,694
+45
| +2% | +$2.71K | ﹤0.01% | 3703 |
|
|
2020
Q4 | $139K | Buy |
2,649
+806
| +44% | +$42.3K | ﹤0.01% | 3591 |
|
|
2020
Q3 | $64K | Buy |
1,843
+29
| +2% | +$1.01K | ﹤0.01% | 3697 |
|
|
2020
Q2 | $157K | Buy |
1,814
+857
| +90% | +$74.2K | ﹤0.01% | 3204 |
|
|
2020
Q1 | $55K | Sell |
957
-57
| -6% | -$3.28K | ﹤0.01% | 3438 |
|
|
2019
Q4 | $73K | Buy |
1,014
+285
| +39% | +$20.5K | ﹤0.01% | 3657 |
|
|
2019
Q3 | $43K | Sell |
729
-77
| -10% | -$4.54K | ﹤0.01% | 3887 |
|
|
2019
Q2 | $75K | Sell |
806
-2,104
| -72% | -$196K | ﹤0.01% | 4177 |
|
|
2019
Q1 | $234K | Buy |
2,910
+52
| +2% | +$4.18K | ﹤0.01% | 3833 |
|
|
2018
Q4 | $464K | Buy |
2,858
+1,715
| +150% | +$278K | ﹤0.01% | 3341 |
|
|
2018
Q3 | $186K | Buy |
1,143
+175
| +18% | +$28.5K | ﹤0.01% | 4145 |
|
|
2018
Q2 | $145K | Buy |
+968
| New | +$145K | ﹤0.01% | 4265 |
|